MONICA DECICCO: Open Payments
NPI 1659426864 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 35 payments from 11 companies in 2025. Trend: 2023 $795 · 2024 $644 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 9 | $185 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $114 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Biogen, Inc. | 4 | $77 |
| Organon LLC | 3 | $58 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Exeltis, USA Inc. | 3 | $49 |
| CooperSurgical, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: FEMLYV, MYFEMBREE, ZURZUVAE, INTRAROSA, NEXPLANON, Exparel, SLYND, Paragard T 380A.
Industry payments across IL — which companies pay providers there.
